Illumina’s Staff Product Manager of Infectious Disease Michael Oberholzer, Ph.D., and Chief Medical Officer Phil Febbo, M.D., offer their perspective on the novel Coronavirus SARS-CoV-2 (2019-nCoV) outbreak.
Copy and paste this URL into your WordPress site to embed
